“We are very pleased with the Court's decision,” said
About
Investor Inquiries: ICR WestwickeMike Piccinino , CFA OrganoIR@westwicke.com Press and Media Inquiries: Organogenesis communications@organo.com
Source:
2024 GlobeNewswire, Inc., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.005 USD | -0.83% | +25.10% | -26.89% |
01:01pm | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
“We are very pleased with the Court's decision,” said
About
Investor Inquiries: ICR WestwickeMike Piccinino , CFA OrganoIR@westwicke.com Press and Media Inquiries: Organogenesis communications@organo.com
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-26.89% | 402M | |
+26.33% | 44.96B | |
-0.64% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.51% | 26.08B | |
-21.29% | 19.03B | |
+5.96% | 12.75B | |
+28.34% | 12.06B | |
-3.30% | 11.75B |